HRES 685 · 119th Congress · Health

Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.

Introduced 2025-09-09· Sponsored by Rep. Cammack, Kat [R-FL-3]· House

Bill Progress

1
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the House Committee on Energy and Commerce.(2025-09-09)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H. Res. 685 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. RES. 685 Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES September 9, 2025 Mrs. Cammack (for herself, Ms. Kamlager-Dove, Mrs. Kim, Ms. Pettersen, Mrs. Hinson, Ms. Adams, Mrs. Cherfilus-McCormick, and Mr. Landsman) submitted the following resolution; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ RESOLUTION Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes. Whereas antiphospholipid syndrome (APS) is a condition in which the immune system of an individual mistakenly produces antibodies that increase the risk of blood clots; Whereas APS can increase the risk of miscarriages, stillbirths, and pregnancy complications; Whereas professional medical associations and guideline-setti…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (8)

5 Democrats3 Republicans